Sienna, MannKind stocks move on new trial data
Two Westlake Village biotech companies released new data from product trials, spurring stock moves and presaging capital raises to fund further research and development. Analysts remained optimistic on Sienna Biopharmaceuticals despite an 18 percent drop in the stock June 10, after the company released results from clinical trials of its psoriasis product. Despite the Read More →
Wells Fargo names new head for commercial banking in region
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Ventura County eliminating jobs at health care agency
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Alaka’i unveils prototype of flying car in Newbury Park
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Fienup: Federal Reserve actions diminish economic future
By Matthew Fienup For years, we have been critical of Federal Reserve policy and the significant impacts that it is having on the U.S. economy. As we wrote in 2017, “U.S. monetary policy is among the greatest of internal risks to U.S. economic growth.” And in 2018, “Extraordinary policy experimentation undertaken by the Federal Reserve Read More →
J.P. Morgan Private Bank opening office in Westlake Village
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen stock climbs on cancer drug test news
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
